Adamis Pharmaceuticals Corporation ADMP
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 7.25M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -29.25
- Beta
- 1.26
- Short ratio
- 0.57
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 21, 2023
- 50-d avg
- 3.10
- 200-d avg
- 9.63
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ADMP has not been loaded yet. Try again in a moment.
Altman Z-Score
-59.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -1.0×
P/S 5.3×
P/B -31.4×
P/FCF -1.0×
EV/EBITDA -0.0×
EV/Sales 5.2×
FCF Yield -104.8%
Gross Margin -30.1%
Operating Margin -526.9%
Net Margin -550.9%
ROE 3242.2%
ROIC 20462.3%
ROA -239.7%
Revenue 115.3%
Operating Income 21.9%
EPS (diluted) 27.1%
Free Cash Flow 31.9%
Current Ratio 0.8×
Quick Ratio 0.7×
Debt / Equity -0.4×
Net Debt / EBITDA 0.0×
Interest Coverage -568×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31